Federal Government Scrutinizing Sales Rep Dealings With Trial Results

Medical device manufacturers who let their sales representatives disseminate clinical trial results for unapproved devices or off-label indications are skating on thin ice, according to the Department of Justice and the HHS Office of Inspector General